As such, "the combination of T-DXd and pertuzumab may represent a new first-line standard of care for patients with ...

CHICAGO -- Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line ...

Market participants expect Sybos to make a total exit from Ebos when escrow arrangements expire as it is diversifying away ...

In 2013, listed health and animal care company Ebos swallowed a giant. In June of that year, Ebos shareholders overwhelmingly ...